UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000033140
Receipt number R000037212
Scientific Title Investigation of influencing factors of mild cognitive impairment on heart failure disease management
Date of disclosure of the study information 2018/07/01
Last modified on 2022/05/18 05:32:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Investigation of influencing factors of mild cognitive impairment on heart failure disease management

Acronym

Influence of mild cognitive impairment on heart failure disease management

Scientific Title

Investigation of influencing factors of mild cognitive impairment on heart failure disease management

Scientific Title:Acronym

Influence of mild cognitive impairment on heart failure disease management

Region

Japan


Condition

Condition

Heart failure

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate disease management status of heart failure patients with mild cognitive impairment in comparison to those with normal cognitive function in Japan.

Basic objectives2

Others

Basic objectives -Others

Observational study

Trial characteristics_1

Exploratory

Trial characteristics_2

Others

Developmental phase

Not applicable


Assessment

Primary outcomes

Relationship between cognitive function and disease management status (self-care behavior and re-hospitalization) of heart failure patients.

Key secondary outcomes

1. Calculation of cognitive impairment prevalence of inpatients with heart failure during the study.(MoCA-J)
2. Comparison of demographic and clinical features, self-care (EHFScBS), QOL(Euro QOL-5D-5L), and locus of control (General locus of control scale) between patients with normal cognitive function and patients with mild cognitive impairment at baseline.
3. Comparison of self-care (EHFScBS), QOL(Euro QOL-5D-5L),unplanned hospital visits, re-hospitalization, and length of hospital stay between patients with normal cognitive function and patients with mild cognitive impairment (baseline to 3 months).
4. Comparison of re-hospitalization rate 3 months after discharge from patients with normal cognitive function and patients with mild cognitive impairment.
5. Relationship between cognitive subscale scores of MoCA-J and self-care scale.


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1. Those who participated in the cardiac rehabilitation at Hiroshima University Hospital for the diagnosis of heart failure.
2. Patients who are judged to be normal cognitive function and mild cognitive impairment by the cognitive function screening test.
3. Patient who agreed to participate in this research.

Key exclusion criteria

1. Patients who are unable to evaluate cognitive functions due to severe neuropsychiatric disorders, stroke, vision disorders, and hearing impairment.
2. Patients with dementia.
3. Patients who are unable to participate in the study.

Target sample size

130


Research contact person

Name of lead principal investigator

1st name Michiko
Middle name
Last name Moriyama

Organization

Hiroshima University

Division name

Nursing Science

Zip code

734-8553

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8553 Japan

TEL

+81-82-257-5365

Email

morimich@hiroshima-u.ac.jp


Public contact

Name of contact person

1st name Michiko
Middle name
Last name Moriyama

Organization

Hiroshima University

Division name

Nursing Science

Zip code

734-8553

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8553 Japan

TEL

+81-82-257-5367

Homepage URL


Email

morimich@hiroshima-u.ac.jp


Sponsor or person

Institute

Hiroshima University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor

Hiroshima University Hospital Heart Failure Center
University of the Ryukyus hospital

Name of secondary funder(s)



IRB Contact (For public release)

Organization

Hiroshima University

Address

Kasumi 1-2-3 Minami-ku, Hiroshima 734-8553 Japan

Tel

+81-82-257-5367

Email

morimich@hiroshima-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

・広島大学病院心不全センター(広島県)/
Hiroshima University Hospital Heart Failure Center
・琉球大学医学部付属病院(沖縄県)/University of the Ryukyus hospital


Other administrative information

Date of disclosure of the study information

2018 Year 07 Month 01 Day


Related information

URL releasing protocol

unset

Publication of results

Unpublished


Result

URL related to results and publications

unset

Number of participants that the trial has enrolled

74

Results

Three months after discharge, characteristics were compared between the MCI and normal groups on the heart failure self-care scale and quality of life.
The results showed that there was no significant difference in heart failure self-care ability, and patients with MCI were able to maintain the same level as normal patients.
In terms of QOL, the MCI group had significantly lower VAS.

Results date posted

2022 Year 05 Month 18 Day

Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics

Comparing the MCI and normal groups at enrollment, the MCI group was significantly older, had higher rates of diabetes comorbidity, fewer years of education, higher HbA1c, and lower quality of life.
There were no significant differences in self-care ability or locus of control, and the results were similar to those of normal individuals even if they had MCI.

Participant flow

Eligibility benchmark n=80
Consent to obtain n=6
Research registrants n=74
MCI group at the time of registration n=44
Normal group at the time of registration n=30
MCI group after 3 months of discharge n=35
Normal group after 3 months of discharge n=23

Adverse events

None

Outcome measures

Three months after discharge, characteristics were compared between the MCI and normal groups on the heart failure self-care scale and quality of life.
The results showed that there was no significant difference in heart failure self-care ability, and patients with MCI were able to maintain the same level as normal patients.
In terms of QOL, the MCI group had significantly lower VAS.
The readmission rate after 3 months of discharge between the MCI and normal groups tended to be higher in the MCI group, but there was no significant difference.

Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 11 Month 16 Day

Date of IRB

2017 Year 12 Month 01 Day

Anticipated trial start date

2017 Year 12 Month 01 Day

Last follow-up date

2021 Year 03 Month 31 Day

Date of closure to data entry

2021 Year 06 Month 30 Day

Date trial data considered complete

2021 Year 10 Month 01 Day

Date analysis concluded

2022 Year 03 Month 31 Day


Other

Other related information

1. Calculation of cognitive impairment prevalence of inpatients with heart failure during the study (MoCA-J).
2. Comparison of demographic and clinical features, self-care (EHFScBS), QOL(Euro QOL-5D-5L), and locus of control (General locus of control scale) between patients with normal cognitive function and patients with mild cognitive impairment at baseline.
3. Comparison of self-care (EHFScBS), QOL(Euro QOL-5D-5L),unplanned hospital visits, re-hospitalization, and length of hospital stay between patients with normal cognitive function and patients with mild cognitive impairment (baseline to 3 months).
4. Comparison of re-hospitalization rate 3 months after discharge from patients with normal cognitive function and patients with mild cognitive impairment.
5. Relationship between cognitive subscale scores of MoCA-J and self-care scale.


Management information

Registered date

2018 Year 06 Month 25 Day

Last modified on

2022 Year 05 Month 18 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000037212


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name